Jim Simons acquired 38k PharmaCyte Biotech shares worth $14.5k. That's 0.00% of their equity portfolio (2857th largest holding). The first PharmaCyte Biotech trade was made in Q2 2023. Since then Jim Simons bought shares nine more times and sold shares on three occasions. The investor's estimated purchase price is $70.3k, resulting in a loss of 79%.